Accept Refuse

EUR-Lex Access to European Union law

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Document 31998R2686

Commission Regulation (EC) No 2686/98 of 11 December 1998 amending Annexes I and II of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance)

OJ L 337, 12.12.1998, p. 20–23 (ES, DA, DE, EL, EN, FR, IT, NL, PT, FI, SV)
Special edition in Czech: Chapter 03 Volume 024 P. 187 - 190
Special edition in Estonian: Chapter 03 Volume 024 P. 187 - 190
Special edition in Latvian: Chapter 03 Volume 024 P. 187 - 190
Special edition in Lithuanian: Chapter 03 Volume 024 P. 187 - 190
Special edition in Hungarian Chapter 03 Volume 024 P. 187 - 190
Special edition in Maltese: Chapter 03 Volume 024 P. 187 - 190
Special edition in Polish: Chapter 03 Volume 024 P. 187 - 190
Special edition in Slovak: Chapter 03 Volume 024 P. 187 - 190
Special edition in Slovene: Chapter 03 Volume 024 P. 187 - 190
Special edition in Bulgarian: Chapter 03 Volume 026 P. 100 - 103
Special edition in Romanian: Chapter 03 Volume 026 P. 100 - 103

No longer in force, Date of end of validity: 05/07/2009; Implicitly repealed by 32009R0470

ELI: http://data.europa.eu/eli/reg/1998/2686/oj

12.12.1998   

EN

Official Journal of the European Communities

L 337/20


COMMISSION REGULATION (EC) No 2686/98

of 11 December 1998

amending Annexes I and II of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin

(Text with EEA relevance)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Community,

Having regard to Council Regulation (EEC) No 2377/90 of 26 June 1990 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (1), as last amended by Commission Regulation (EC) No 2560/98 (2) and in particular Articles 6, 7 and 8 thereof,

Whereas, in accordance with Regulation (EEC) No 2377/90, maximum residue limits must be established progressively for all pharmacologically active substances which are used within the Community in veterinary medicinal products intended for administration to food-producing animals;

Whereas maximum residue limits should be established only after the examination within the Committee for Veterinary Medicinal Products of all the relevant information concerning the safety of residues of the substance concerned for the consumer of foodstuffs of animal origin and the impact of residues on the industrial processing of foodstuffs;

Whereas, in establishing maximum residue limits for residues of veterinary medicinal products in foodstuffs of animal origin, it is necessary to specify the animal species in which residues may be present, the levels which may be present in each of the relevant meat tissues obtained from the treated animal (target tissue) and the nature of the residue which is relevant for the monitoring of residues (marker residue);

Whereas, for the control of residues, as provided for in appropriate Community legislation, maximum residue limits should usually be established for the target tissues of liver or kidney; whereas, however, the liver and kidney are frequently removed from carcasses moving in international trade, and maximum residue limits should therefore also always be established for muscle or fat tissues;

Whereas, in the case of veterinary medicinal products intended for use in laying birds, lactating animals or honey bees, maximum residue limits must also be established for eggs, milk or honey;

Whereas flumethrin should be inserted into Annex I to Regulation (EEC) No 2377/90;

Whereas oleyloleate, calcium glucoheptonate, calcium glucono glucoheptonate, calcium gluconolactate, calcium glutamate, nickel gluconate, nickel sulphate, sodium hypophosphite, bacitracin, bronopol, cetostearyl alcohol, menadione, phytomenadione, 2-pyrrolidone, sodium cetostearyl sulphate, wool alcohols, lespedeza capitata, majoranae herba, medicago sativa extractum, sinapis nigrae semen and flumethrin should be inserted into Annex II to Regulation (EEC) No 2377/90;

Whereas a period of 60 days should be allowed before the entry into force of this Regulation in order to allow Member States to make any adjustment which may be necessary to the authorisations to place the veterinary medicinal products concerned on the market which have been granted in accordance with Council Directive 81/851/EEC (3), as last amended by Directive 93/40/EEC (4) to take account of the provisions of this Regulation;

Whereas the measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,

HAS ADOPTED THE FOLLOWING REGULATION:

Article 1

Annexes I and II of Regulation (EEC) No 2377/90 are hereby amended as set out in the Annex hereto.

Article 2

This Regulation shall enter into force on the 60th day following its publication in the Official Journal of the European Communities.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 11 December 1998.

For the Commission

Martin BANGEMANN

Member of the Commission


(1)  OJ L 224, 18. 8. 1990, p. 1.

(2)  OJ L 320, 28. 11. 1998, p. 28.

(3)  OJ L 317, 6. 11. 1981, p. 1.

(4)  OJ L 214, 24. 8. 1993, p. 31.


ANNEX

A.   Annex I to Regulation (EC) No 2377/90 is amended as follows:

2.

Antiparasitic agents

2.2.

Agents acting against ectoparasites

2.2.3.

Pyrethroids

Pharmacologically active substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

‘Flumethrin

Flumethrin (sum of trans-Z isomers)

Bovine

10 μg/kg

Muscle

 

150 μg/kg

Fat

 

20 μg/kg

Liver

 

10 μg/kg

Kidney

 

30 μg/kg

Milk’

 

B.   Annex II to Regulation (EC) No 2377/90 is amended as follows:

1.

Inorganic chemicals

Pharmacologically active substance(s)

Animal species

Other provisions

‘Calcium glucoheptonate

All food-producing species

 

Calcium glucono glucoheptonate

All food-producing species

 

Calcium gluconolactate

All food-producing species

 

Calcium glutamate

All food-producing species

 

Nickel gluconate

All food-producing species

 

Nickel sulphate

All food-producing species

 

Sodium hypophosphite

All food-producing species’

 

2.

Organic compounds

Pharmacologically active substance(s)

Animal species

Other provisions

‘2-Pyrrolidone

All food-producing species

At parenteral doses up to 40 mg/kg bw

Bacitracin

Bovine

For intramammary use in lactating cows only and for all tissues except milk

Bronopol

Salmonidae

For use only on farmed fertilised eggs

Cetostearyl alcohol

All food-producing species

 

Flumethrin

Honey bees

 

Menadione

All food-producing species

 

Oleyloleate

All food-producing species

For topical use only

Phytomenadione

All food-producing species

 

Sodium cetostearyl sulphate

All food-producing species

For topical use only

Wool alcohols

All food-producing species

For topical use only’

6.

Substances of vegetable origin

Pharmacologically active substance(s)

Animal species

Other provisions

‘Lespedeza capitata

All food-producing species

 

Majoranae herba

All food-producing species

 

Medicago sativa extractum

All food-producing species

For topical use only

Sinapis nigrae semen

All food-producing species’

 


Top